Pharosyn is a London-based startup founded in 2025 by Cambridge graduates Stephen Cowley and Joshua Hampson that builds custom AI infrastructure for commercial decision-making in pharma. Its platform continuously monitors thousands of clinical, regulatory, and commercial sources — trial data, deals, hiring trends, epidemiology, and social media — and turns them into traceable strategic reports and alerts spanning competitive intelligence, portfolio strategy, forecasting, market research, and business development licensing. Senior directors at a top-10 biopharmaceutical company and several mid-sized pharma firms use it daily, cutting report production time from about four hours to roughly 15 minutes.
1
Round
1
Industry
5
Tags
Sep 2, 2026
Latest raise
Funding activity · 1 round
Sep 2, 2026
$3M
Seed
Led by Moonfire Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
